Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO Monographs For 28 Medicinal Plants Available, Volume II Under Way

This article was originally published in The Tan Sheet

Executive Summary

The World Health Organization's Monographs on Selected Medicinal Plants, Vol. 1, encompassing 28 plants including chamomile, echinacea, ephedra, ginkgo biloba, ginseng and senna, is now available through WHO and the American Botanical Council.

You may also be interested in...



GNC seeking relief of liability for FTC order violations by franchisees.

GNC SEEKING LIABILITY RELIEF FOR FRANCHISEE FTC ORDER VIOLATIONS in a petition filed July 15. General Nutrition, Inc. is asking the Federal Trade Commission to reopen and modify two final orders from 1969 and 1989 and a 1994 consent decree barring the retailer from making certain claims for some of its products. When the orders were executed, GNC and FTC did not foresee the importance franchise stores would hold for GNC's business. Now, over one-third of GNC's total domestic stores are franchises, and the firm does not believe it should be held responsible for advertising used by non-company-owned stores.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090208

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel